Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

WHiTE 8 COPAL, a randomised controlled trial embedded in the World Hip Trauma Evaluation study, opened to recruitment on Friday, August 17th and recruited its first patient on the same day. WHiTE 8 will be recruiting for 30 months at 24 hospitals across the UK. The study aims to establish whether a high dose dual antibiotic regime has fewer infections compared to low dose single antibiotic cement in the treatment of cemented hemiarthroplasties in patients who have suffered a displaced intracapsular fracture of the neck of femur. For more information about the WHiTE 8 trial, please visit https://white8.octru.ox.ac.uk/